share_log

4: Statement of changes in beneficial ownership of securities-Director Park Min-Chul

4: Statement of changes in beneficial ownership of securities-Director Park Min-Chul

4：持股變動聲明-董事 Park Min-Chul
美股SEC公告 ·  2024/07/19 09:36

Moomoo AI 已提取核心訊息

In a recent transaction dated 05/24/2023, Park Min-Chul engaged in a stock market activity involving shares of ZyVersa Therapeutics, Inc. (ZVSA.US). The specifics of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the transaction, have not been disclosed. Following the action, the updated number of shares held by Park Min-Chul in ZyVersa Therapeutics remains undisclosed. This transaction could potentially signal insider confidence or concern to investors, but without further details, the implications for the stock's performance are unclear.
In a recent transaction dated 05/24/2023, Park Min-Chul engaged in a stock market activity involving shares of ZyVersa Therapeutics, Inc. (ZVSA.US). The specifics of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the transaction, have not been disclosed. Following the action, the updated number of shares held by Park Min-Chul in ZyVersa Therapeutics remains undisclosed. This transaction could potentially signal insider confidence or concern to investors, but without further details, the implications for the stock's performance are unclear.
在最近的一次交易中，樸敏哲參與了ZyVersa Therapeutics,Inc.(ZVSA.US)股票市場活動。交易的具體細節，包括交易的股票數量、股票的性質、交易價格和交易的總價值，尚未披露。此次行動後，樸敏哲在ZyVersa Therapeutics持有股份的數量更新仍未公開。這次交易可能會向投資者表明內部人員的信心或憂慮，但由於缺乏進一步的細節，對於股票表現的影響還不確定。
在最近的一次交易中，樸敏哲參與了ZyVersa Therapeutics,Inc.(ZVSA.US)股票市場活動。交易的具體細節，包括交易的股票數量、股票的性質、交易價格和交易的總價值，尚未披露。此次行動後，樸敏哲在ZyVersa Therapeutics持有股份的數量更新仍未公開。這次交易可能會向投資者表明內部人員的信心或憂慮，但由於缺乏進一步的細節，對於股票表現的影響還不確定。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    相關股票 相關股票
    代碼 迷你走勢 最新價
    Nutriband
    NTRB
    -- 7.340
    Eterna Therapeutics
    ERNA
    -- 0.635
    Tonix Pharmaceuticals
    TNXP
    -- 0.3190
    ImmunoPrecise Antibodies
    IPA
    -- 0.645
    Sonnet BioTherapeutic
    SONN
    -- 2.0000
    解鎖完整榜單
    熱門中概股
    追蹤最熱門的中概股實時資訊。
    熱門討論
    特斯拉業績在即：股價能否繼續攀升？
    🎙️討論： 1. 面對特朗普回歸，特斯拉股價能否在2025年繼續攀升？ 2. 特斯拉將於1月29日收盤後公布財報，你認為會超出市場預期嗎？ 展开
    🚗 特斯拉第四季度下跌：是時候買入了，還是風險太高？📉